Article Details
Retrieved on: 2024-07-16 16:41:44
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the safety and efficacy of infant immunization against respiratory syncytial virus (RSV) with monoclonal antibodies, clarifying that deaths in clinical trials of nirsevimab were not related to the drug. This relates to public health through vaccination topics and biotechnological advancements.
Article found on: www.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here